Zymergen is a science and material innovation company rethinking biology and reimagining the world. A World Economic Forum Tech Pioneer, Zymergen partners with nature to create never-before-imagined materials and products across industries —from agriculture to electronics, personal care to pharmaceuticals, and more.

Using a powerful combination of biology, machine learning, data science and automation, the company’s proprietary metagenomic library helps catalyze new discoveries. Zymergen’s revolutionary process produces better performing bio-based materials in a way which is faster, less expensive, more efficient and more sustainable for Fortune 1000 companies and major corporations across the globe. Its partners have sold over $1 billion worth of products using Zymergen innovations and microbial strains.



Press Releases on our investor site





An automated Molecular Devices QPix 420 colony picker deposits 96 distinct strains into liquid media for outgrowth and downstream testing.

Two Meca500 six-axis robot arms transfer 384-well plates from a Magnemover Lite magnetic conveyor system into automated thermal cyclers that will perform PCR. They are a small part of our modular automation system composed of Reconfigurable Automation Carts (RACs).

Powered by Zymergen’s custom image analysis pipeline, a Molecular Devices QPix 420 picks microbial colonies from a high-throughput agar plate.

A chemist holds up a sample of Hyaline, a flexible, bio-fabricated film, in one of Zymergen’s test labs.

An automation engineer swaps out an automated thermal cycler on one Zymergen’s Reconfigurable Automation Carts.

Infors HT solid-state fermentation bioreactors that are fully equipped for on-line analysis in our Fermentation suite.

The images provided within this media kit are available for editorial use only. “Editorial use” is defined as the use of images/content for editorial purposes in connection with reporting on Zymergen or Zymergen-related persons, places, matters, topics, or events that are newsworthy or of general public interest. Permission to use images for anything other than editorial purposes must be specifically granted in writing by an authorized Zymergen representative prior to use.


Vertical Logo Lock-up

Horizontal Logo Lock-up


Mike Dulin
Director of Communications
Copy link
Powered by Social Snap